BLTE
Belite Bio, Inc
There isn't enough reported data to score BLTE yet.
BLTE Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
BLTE's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
BLTE PE Valuation
BLTE has no meaningful PE right now: it lost money over the past year.
BLTE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Moderate |
Analysts expect BLTE's losses to shrink, with revenue growing.
BLTE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$2.76 | -$1.22 |
| Q2 2025 | -$1.54 | -$0.31 |
| Q2 2022 | -$0.68 | +$0.24 |
| Q1 2022 | -$0.81 | -$0.02 |
| Q4 2021 | -$1.02 | -$0.36 |
BLTE lost $2.76 per share over the past year, a bigger loss than the year before.
BLTE Quarterly Revenue
BLTE's revenue is shrinking: $0 last quarter.
BLTE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | $0 |
| Q1 2026 | $0 | $0 |
| Q4 2025 | -$10.6K | -$10.6K |
| Q3 2025 | $0 | $0 |
| Q2 2025 | $0 | $0 |
| Q1 2025 | $0 | $0 |
| Q4 2024 | $0 | $0 |
| Q3 2024 | $0 | $0 |
BLTE's free cash flow was −$10,563 over the past year, against $0 the year before.
BLTE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.8% | +314K shares |
| 1 year | +23% | +7.6M shares |
| 3 years | +56% | +14.4M shares |
| 5 years | +320% | +30.6M shares |
| Available history | +360% | +31.4M shares |
BLTE has 40M diluted shares, up 23% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BLTE hasn't bought back shares in the past year.
BLTE Net Leverage
BLTE's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BLTE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.6 | Neutral |
| Stochastic | 32.1 | Neutral |
BLTE's weekly RSI is 57 (neutral) and its Stochastic is 32 (neutral).
BLTE PE vs Healthcare Sector
BLTE has no meaningful PE right now: it lost money over the past year.
BLTE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $156.3 | 8.7% above |
| 20 week MA | $159.3 | 6.7% above |
| 50 week MA | $159.1 | 6.9% above |
| 100 week MA | $114.2 | 49% above |
| 200 week MA | $77.1 | 121% above |
BLTE is in an uptrend: it's above all five of its weekly moving averages, and 121% above its 200-week average.
BLTE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $10.6 | $30.9 | +192% |
| 2023 | $30.9 | $45.8 | +48% |
| 2024 | $45.8 | $62.0 | +36% |
| 2025 | $62.0 | $154.9 | +150% |
| 2026 YTD | $154.9 | $170.0 | +9.7% |
BLTE has finished every year since 2022 higher, and it's up 9.7% so far in 2026.